Soluhoidot

Soluhoidot, meaning cell therapies in English, refers to a broad category of medical treatments that involve introducing, removing, or modifying cells in a patient's body to treat a disease or condition. These therapies leverage the power of living cells to restore or enhance biological functions.

One of the most prominent examples of soluhoidot is gene therapy, where cells are genetically engineered to correct or compensate for genetic defects. This can involve introducing a functional gene to replace a mutated one or altering cells to produce therapeutic proteins. Another significant area is stem cell therapy, which utilizes the regenerative potential of stem cells. These undifferentiated cells can develop into various specialized cell types, offering hope for repairing damaged tissues and organs.

CAR T-cell therapy is a notable advancement in cancer treatment, a type of soluhoidot. In this approach, a patient's own T-cells (a type of immune cell) are genetically modified in a lab to recognize and attack cancer cells. These enhanced T-cells are then infused back into the patient.

The development and application of soluhoidot are rapidly evolving, with ongoing research exploring new cell types, delivery methods, and target diseases. While promising, these therapies also face challenges related to efficacy, safety, manufacturing complexity, and cost. Regulatory frameworks are continuously being adapted to address the unique aspects of these living medicines.